158 related articles for article (PubMed ID: 38108211)
21. Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma.
Kubo S; Takemura S; Tanaka S; Shinkawa H; Nishioka T; Nozawa A; Kinoshita M; Hamano G; Ito T; Urata Y
World J Gastroenterol; 2015 Jul; 21(27):8249-55. PubMed ID: 26217076
[TBL] [Abstract][Full Text] [Related]
22. Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease.
Cho JY; Paik YH; Sohn W; Cho HC; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
Gut; 2014 Dec; 63(12):1943-50. PubMed ID: 24615378
[TBL] [Abstract][Full Text] [Related]
23. HMMR alleviates endoplasmic reticulum stress by promoting autophagolysosomal activity during endoplasmic reticulum stress-driven hepatocellular carcinoma progression.
He L; Li H; Li C; Liu ZK; Lu M; Zhang RY; Wu D; Wei D; Shao J; Liu M; Wei HL; Zhang C; Wang Z; Kong LM; Chen ZN; Bian H
Cancer Commun (Lond); 2023 Sep; 43(9):981-1002. PubMed ID: 37405956
[TBL] [Abstract][Full Text] [Related]
24. Influence of miR-520e-mediated MAPK signalling pathway on HBV replication and regulation of hepatocellular carcinoma cells via targeting EphA2.
Tian JH; Liu WD; Zhang ZY; Tang LH; Li D; Tian ZJ; Lin SW; Li YJ
J Viral Hepat; 2019 Apr; 26(4):496-505. PubMed ID: 30521133
[TBL] [Abstract][Full Text] [Related]
25. Early and late recurrence of surgically resected hepatitis B virus-related hepatocellular carcinoma on nucleos(t)ide analogues therapy.
Wu CJ; Chau GY; Lee IC; Huo TI; Su CW; Hou MC; Huang YH
J Formos Med Assoc; 2021 Aug; 120(8):1563-1571. PubMed ID: 33334659
[TBL] [Abstract][Full Text] [Related]
26. Prevention of hepatitis B virus-associated liver diseases by antiviral therapy.
Tawada A; Kanda T; Imazeki F; Yokosuka O
Hepatol Int; 2016 Jul; 10(4):574-93. PubMed ID: 27026375
[TBL] [Abstract][Full Text] [Related]
27. Prevention of hepatocellular carcinoma in hepatitis B virus infection.
Lim SG; Mohammed R; Yuen MF; Kao JH
J Gastroenterol Hepatol; 2009 Aug; 24(8):1352-7. PubMed ID: 19702903
[TBL] [Abstract][Full Text] [Related]
28. Autophagy and microRNA in hepatitis B virus-related hepatocellular carcinoma.
Wu SY; Lan SH; Liu HS
World J Gastroenterol; 2016 Jan; 22(1):176-87. PubMed ID: 26755869
[TBL] [Abstract][Full Text] [Related]
29. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
[TBL] [Abstract][Full Text] [Related]
30. Expression of a hepatitis B virus pre-S2 deletion mutant in the liver results in hepatomegaly and hepatocellular carcinoma in mice.
Teng YC; Neo JC; Wu JC; Chen YF; Kao CH; Tsai TF
J Pathol; 2017 Mar; 241(4):463-474. PubMed ID: 27868197
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis B Virus-Encoded MicroRNA (HBV-miR-3) Regulates Host Gene PPM1A Related to Hepatocellular Carcinoma.
Chavalit T; Nimsamer P; Sirivassanametha K; Anuntakarun S; Saengchoowong S; Tangkijvanich P; Payungporn S
Microrna; 2020; 9(3):232-239. PubMed ID: 31686644
[TBL] [Abstract][Full Text] [Related]
32. Effects of antiviral therapy on preventing liver tumorigenesis and hepatocellular carcinoma recurrence.
Tan ZM; Sun BC
World J Gastroenterol; 2013 Dec; 19(47):8895-901. PubMed ID: 24379613
[TBL] [Abstract][Full Text] [Related]
33. Liver Carcinogenesis Suppression in Chronic Hepatitis B in the Nucleoside Analogues Era.
Nishikawa H; Kim SK; Asai A
In Vivo; 2024; 38(1):40-47. PubMed ID: 38148074
[TBL] [Abstract][Full Text] [Related]
34. Effect of Nucleos(t)ide Analogs on Patients with Intermediate and Advanced Hepatitis B Virus-Related Hepatocellular Carcinoma.
Jian ZW; Wu XW; Chen ZX; Wang JC; Peng JY; Lao XM
Dig Dis Sci; 2019 Aug; 64(8):2187-2198. PubMed ID: 30815819
[TBL] [Abstract][Full Text] [Related]
35. Prevention of hepatocellular carcinoma: beyond hepatitis B vaccination.
Kim MN; Han KH; Ahn SH
Semin Oncol; 2015 Apr; 42(2):316-28. PubMed ID: 25843736
[TBL] [Abstract][Full Text] [Related]
36. Resistance of ground glass hepatocytes to oral antivirals in chronic hepatitis B patients and implication for the development of hepatocellular carcinoma.
Tsai HW; Lin YJ; Wu HC; Chang TT; Wu IC; Cheng PN; Yen CJ; Chan SH; Huang W; Su IJ
Oncotarget; 2016 May; 7(19):27724-34. PubMed ID: 27027237
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis B virus replication and liver disease progression: the impact of antiviral therapy.
Liaw YF
Antivir Ther; 2006; 11(6):669-79. PubMed ID: 17310811
[TBL] [Abstract][Full Text] [Related]
38. Endoplasmic reticulum stress promotes HBV production by enhancing use of the autophagosome/multivesicular body axis.
Wang X; Wei Z; Cheng B; Li J; He Y; Lan T; Kemper T; Lin Y; Jiang B; Jiang Y; Meng Z; Lu M
Hepatology; 2022 Feb; 75(2):438-454. PubMed ID: 34580902
[TBL] [Abstract][Full Text] [Related]
39. Comparable Efficacy Between Ongoing Versus Initiation of Antiviral Therapy at Treatment for HBV-related Hepatocellular Carcinoma.
Kim MN; Kim BK; Roh YH; Choi NR; Yu SJ; Kim SU
Clin Gastroenterol Hepatol; 2022 Aug; 20(8):1877-1880.e3. PubMed ID: 35181566
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis B Virus Combo Mutations Improve the Prediction and Active Prophylaxis of Hepatocellular Carcinoma: A Clinic-Based Cohort Study.
Yin J; Wang J; Pu R; Xin H; Li Z; Han X; Ding Y; Du Y; Liu W; Deng Y; Ji X; Wu M; Yu M; Zhang H; Wang H; Thompson TC; Ni W; Cao G
Cancer Prev Res (Phila); 2015 Oct; 8(10):978-88. PubMed ID: 26290395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
